Skip to main content

Phage display of epitopes from HIV-1 elicits strong cytolytic responses in vitroand in vivo

  • Chapter
Progress in Basic and Clinical Immunology

Abstract

Vaccines based on synthetic peptides representing epitopes recognized by T-helper or cytolytic T-cells have been widely investigated as the basis for effective vaccines. However, their efficacy suffers from a number of important limitations. First, they are poor immunogens and exhibit short life-spans both in serum and within the cell (1). Secondly, the amount of peptide required to bind a threshold number of MHC class II molecules on the surface of an APC is reportedly higher than the minimal amount needed to bind to class II MHC molecules in the intracellular compartment in which the processing of the corresponding parent antigen takes place after internalization (2). Soluble antigens carrying CTL epitopes not only have the same drawbacks, but normally are unable to enter the appropriate intracellular compartment to undergo processing and presentation on class I MHC molecules (3). Thus, delivery systems based on immune-stimulating complexes, liposomes and synthetic lipopeptides have been designed in attempts to circumvent these limitations (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bona, C. A., S. Casares, T. D. Brumeanu. 1998. Towards development of T-cell vaccines.Immunol Today.19: 126–33

    PubMed  CAS  Google Scholar 

  2. Demotz, S., H. M. Grey, A. Sette. 1990. The minimal number of class II MHC-antigen complexes needed for T cell activation.Science.249: 1028–30

    Article  PubMed  CAS  Google Scholar 

  3. Bot, A., S. Bot, S. Antohi, K. Karjalainen, C. Bona. 1996. Kinetics of generation and persistence on membrane class II molecules of a viral peptide expressed on foreign and self proteins.J Immunol.157: 3436–42

    PubMed  CAS  Google Scholar 

  4. Greenwood, J., A. E. Willis, R. N. Perham. 1991. Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens.JMoI Biol.220: 821–7

    Article  CAS  Google Scholar 

  5. Minenkova, O. O., A. A. Ilyichev, G. P. Kishchenko, V. A. Petrenko. 1993. Design of specific immunogens using filamentous phage as the carrier.Gene.128: 85–8

    Article  PubMed  CAS  Google Scholar 

  6. Malik, P., R. N. Perham. 1996. New vectors for peptide display on the surface of filamentous bacteriophage.Gene.171: 49–51

    Article  PubMed  CAS  Google Scholar 

  7. Malik, P., R. N. Perham. 1997. Simultaneous display of different peptides on the surface of filamentous bacteriophage.Nucleic Acids Res.25: 915–6

    Article  PubMed  CAS  Google Scholar 

  8. di Marzo Veronese, F., A. E. Willis, C. Boyer-Thompson, E. Appella, R. N. Perham. 1994. Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on-filamentous bacteriophage. The V3 loop of HIV-1 gp120.JMo1 Biol.243: 167–72

    Article  Google Scholar 

  9. Jelinek, R., T. D. Terry, J. J. Gesell, P. Malik, R. N. Perham, S. J. Opella. 1997. NMR structure of the principal neutralizing determinant of HIV-1 displayed in filamentous bacteriophage coat protein.J Mol Biol.266: 649–55

    Article  PubMed  CAS  Google Scholar 

  10. De Berardinis, P., L. D’Apice, A. Prisco, M. N. Ombra, P. Barba, G. Del Pozzo, S. Petukhov, P. Malik, R. N. Perham, J. Guardiola. 1999. Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages.Vaccine.17: 1434–41

    Article  PubMed  Google Scholar 

  11. Ogg, G. S., X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, A. Hurley, M. Markowitz, D. D. Ho, D. F. Nixon, A. J. McMichael. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.Science.279: 2103–6

    Article  PubMed  CAS  Google Scholar 

  12. Stuhler, G., S. F. Schlossman. 1997. Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets.Proc Natl Acad Sci USA.94: 622–7

    Article  PubMed  CAS  Google Scholar 

  13. Ossendorp, F., E. Mengede, M. Camps, R. Filius, C. J. Melief. 1998. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.JExp Med.187: 693–702

    Article  CAS  Google Scholar 

  14. Keene, J. A., J. Forman. 1982. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes.J Exp Med.155: 768–82

    Article  PubMed  CAS  Google Scholar 

  15. Manca, F., P. De Berardinis, D. Fenoglio, M. N. Ombra, G. Li Pira, D. Saverino, M. Autiero, L. Lozzi, L. Bracci, J. Guardiola. 1996. Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selection.Eur J Immunol.26: 2461–9

    Article  PubMed  CAS  Google Scholar 

  16. Menendez-Arias, L., A. Mas, E. Domingo. 1998. Cytotoxic T-lymphocyte responses to HIV-I reverse transcriptase (review).Viral Immunol. 11: 167–81

    Article  PubMed  CAS  Google Scholar 

  17. Pascolo, S., N. Bervas, J. M. Ure, A. G. Smith, F. A. Lemonnier, B. Perarnau. 1997. FILAA2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice.J Exp Med.185: 2043–51

    Article  PubMed  CAS  Google Scholar 

  18. Vitiello, A., D. Marchesini, J. Furze, L. A. Sherman, R. W. Chesnut. 1991. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex.J Exp Med.173: 1007–15

    Article  PubMed  CAS  Google Scholar 

  19. Ren, J., R. Esnouf, E. Garman, D. Somers, C. Ross, I. Kirby, J. Keeling, G. Darby, Y. Jones, D. Stuart, et al. 1995. High resolution structures of HIV-1 RT from four RT-inhibitor complexes.Nat Struct Biol.2: 293–302

    Article  PubMed  CAS  Google Scholar 

  20. Grimison, B., J. Laurence. 1995. Immunodominant epitope regions of HIV-1 reverse transcriptase: correlations with HIV-1+ serum IgG inhibitory to polymerase activity and with disease progression.J Acquir Immune Defic Syndr Hum Retrovirol.9: 58–68

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Guardiola, J., De Berardinis, P., Sartorius, R., Fanutti, C., Richard, P.N., Pozzo, G.D. (2001). Phage display of epitopes from HIV-1 elicits strong cytolytic responses in vitroand in vivo . In: Mackiewicz, A., Kurpisz, M., Żeromski, J. (eds) Progress in Basic and Clinical Immunology. Advances in Experimental Medicine and Biology, vol 495. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0685-0_40

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0685-0_40

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5194-8

  • Online ISBN: 978-1-4615-0685-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics